Submission Details
| 510(k) Number | K232316 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 03, 2023 |
| Decision Date | March 01, 2024 |
| Days to Decision | 211 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K232316 is an FDA 510(k) clearance for the DEKA Infusion System, DEKA Administration Set, a Controller, Infusion, Intravascular, Electronic (Class II — Special Controls, product code LDR), submitted by Deka Research and Development (Manchester, US). The FDA issued a Cleared decision on March 1, 2024, 211 days after receiving the submission on August 3, 2023. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5725.
| 510(k) Number | K232316 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 03, 2023 |
| Decision Date | March 01, 2024 |
| Days to Decision | 211 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | LDR — Controller, Infusion, Intravascular, Electronic |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5725 |